Bridgewest Ventures
Overview
Bridgewest Ventures is a deep tech incubator and venture capital firm that invests in the biotech, AI, medtech, and clean tech sectors in New Zealand.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioOra | Oct 2025 | Series A | Co-investor |
| Precision Chroma | Jan 2022 | Seed | Lead |
| Luminoma Diagnostics | Dec 2025 | Seed | Co-investor |
| TheiaNova | Nov 2022 | Seed | Co-investor |
| Avasa | Aug 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bridgewest Ventures based?
Bridgewest Ventures is headquartered in Auckland, New Zealand.
When was Bridgewest Ventures founded?
Bridgewest Ventures was founded in 2020.
How many portfolio companies does Bridgewest Ventures have?
Bridgewest Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Bridgewest Ventures's portfolio?
Portfolio companies visible on Caplight include BioOra, Precision Chroma, Luminoma Diagnostics, TheiaNova, Avasa.
What was Bridgewest Ventures's most recent investment shown here?
Bridgewest Ventures's most recent investment in this portfolio sample was in Luminoma Diagnostics in 2025.
What sectors does Bridgewest Ventures focus on?
Bridgewest Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Bridgewest Ventures focus on?
Bridgewest Ventures typically invests at the Early stage.
What is Bridgewest Ventures's AUM?
Bridgewest Ventures's assets under management are estimated between $61.0M and $61.0M.